首页> Vaccines> A Spike-Based mRNA Vaccine Encapsulated in Phospholipid 1,2-Dioleoyl-sn-Glycero-3-PhosphoEthanolamine Containing Lipid Nanoparticles Induced Potent B- and T-Cell Responses Associated with Protection Against SARS-CoV-2 Infection and COVID-19-like Symptoms in Hamsters.

A Spike-Based mRNA Vaccine Encapsulated in Phospholipid 1,2-Dioleoyl-sn-Glycero-3-PhosphoEthanolamine Containing Lipid Nanoparticles Induced Potent B- and T-Cell Responses Associated with Protection Against SARS-CoV-2 Infection and COVID-19-like Symptoms in Hamsters.

导出 LinkOut

翻译打印收藏纠错

第一作者： Afshana,Quadiri

第一单位： Laboratory of Cellular and Molecular Immunology, Gavin Herbert Eye Institute, School of Medicine, University of California Irvine, Irvine, CA 92697, USA.

作者： Afshana,Quadiri ^[1] ; Swayam,Prakash ^[1] ; Latifa,Zayou ^[1] ; Nisha Rajeswari,Dhanushkodi ^[1] ; Amruth,Chilukuri ^[1] ; Gemma,Ryan ^[2] ; Kelly,Wang ^[2] ; Hawa,Vahed ^[3] ; Aziz A,Chentoufi ^[1] ; Lbachir,BenMohamed ^[4]

作者单位： Laboratory of Cellular and Molecular Immunology, Gavin Herbert Eye Institute, School of Medicine, University of California Irvine, Irvine, CA 92697, USA. ^[1] Precision Nanosystems Inc., Vancouver, BC V6P 6T7, Canada. ^[2] Laboratory of Cellular and Molecular Immunology, Gavin Herbert Eye Institute, School of Medicine, University of California Irvine, Irvine, CA 92697, USA.;Department of Vaccines and Immunotherapies, TechImmune LLC, University Lab Partners, Irvine, CA 92660, USA. ^[3] Laboratory of Cellular and Molecular Immunology, Gavin Herbert Eye Institute, School of Medicine, University of California Irvine, Irvine, CA 92697, USA.;Department of Vaccines and Immunotherapies, TechImmune LLC, University Lab Partners, Irvine, CA 92660, USA.;Division of Infectious Diseases and Hospitalist Program, Department of Medicine, School of Medicine, University of California Irvine, Irvine, CA 92697, USA.;Institute for Immunology, School of Medicine, University of California Irvine, Irvine, CA 92697, USA. ^[4]

关键词 COVID-19 DOPE (1,2-dioleoyl-sn-glycero-3-Phosphoethanolamine)lipid nanoparticles mRNA/LNP phospholipid

DOI 10.3390/vaccines13010047

PMID 39852826

发布时间 2025-01-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Vaccines

2025年13卷1期

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Vaccines

2025年13卷1期

检索历史清除

A Spike-Based mRNA Vaccine Encapsulated in Phospholipid 1,2-Dioleoyl-sn-Glycero-3-PhosphoEthanolamine Containing Lipid Nanoparticles Induced Potent B- and T-Cell Responses Associated with Protection Against SARS-CoV-2 Infection and COVID-19-like Symptoms in Hamsters.

Vaccines

相似文献

同项目论文

Vaccines

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

A Spike-Based mRNA Vaccine Encapsulated in Phospholipid 1,2-Dioleoyl-sn-Glycero-3-PhosphoEthanolamine Containing Lipid Nanoparticles Induced Potent B- and T-Cell Responses Associated with Protection Against SARS-CoV-2 Infection and COVID-19-like Symptoms in Hamsters.

Vaccines

相似文献

同项目论文

Vaccines

相关期刊

检索历史清除